|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Apr―14 |
SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research |
Edeildo Ferreira da Silva-Júnior, Weslany Souza Rocha, Peng Zhan |
2 |
[GO] |
2023―Mar―28 |
Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective |
Praveen Kumar Verma, Varun Aggarwal, Ekta Bala, Pawan Kumar, Pankaj Raizada, Pardeep Singh |
3 |
[GO] |
2023―Feb―23 |
Investigating Biomarkers for COVID-19 Morbidity and Mortality |
Marco Fiore, Flavio Maria Ceci, Giampiero Ferraguti, Marco Lucarelli, Antonio Angeloni, Enea Bonci, et al. (+12) Carla Petrella, Silvia Francati, Christian Barbato, Maria Grazia Di Certo, Francesca Gabanella, Francesca Gavaruzzi, Claudio Maria Mastroianni, Antonio Minni, Antonio Greco, Massimo Ralli, Mauro Ceccanti, Luigi Tarani |
4 |
[GO] |
2023―Jan―31 |
Contributions of Medicinal Chemistry During the Pandemic of Covid-19 |
Shampa Ghosh, Jitendra Kumar Sinha |
5 |
[GO] |
2023―Jan―27 |
SAR Based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against Covid-19: A Medicinal
Chemist Perspective |
Mohammad Mumtaz Alam, Anish Madan, Mansi Garg, Garvit Satija, Barkha Sharma, M Shaquiquzzaman, et al. (+6) Mymoona Akhter, Ashif Iqubal, Mohammed Ahmed Khan, Suhel Parvez, Anwesha Das, Khursheed Ahmad Sheikh |
6 |
[GO] |
2022―Dec―27 |
Piezoelectric biosensors and nanomaterials-based therapeutics for coronavirus and other viruses: A Mini-review |
Rakesh Bhaskar, Madeshwaran Sekkarapatti Ramasamy, Sung Soon Han |
7 |
[GO] |
2022―Dec―26 |
Probing the neuro-psychological changes observed with the administration of COVID-19 Drugs |
Indranath Chatterjee, Videsha Bansal |
8 |
[GO] |
2022―Dec―06 |
The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area |
Zhongji Meng |
9 |
[GO] |
2022―Dec―06 |
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors |
Dima A. Sabbah |
10 |
[GO] |
2022―Dec―02 |
Repurposing of chemotherapeutics to combat COVID-19 |
Anil Kumar Saxena, Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede |
11 |
[GO] |
2022―Nov―04 |
Structure Based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design. |
Anusuya Shanmugam, Anbazhagan Venkattappan, M. Michael Gromiha |
12 |
[GO] |
2022―Oct―24 |
Exploring the targets of novel corona virus and docking-based screening of potential natural inhibitors to combat COVID-19 |
Asmita Samadder, Sisir Nandi, Rishita Dey |
13 |
[GO] |
2022―Oct―18 |
Therapeutic Targets and Computational Approaches on Drug Development for COVID-19 |
Anusuya Shanmugam |
14 |
[GO] |
2022―Oct―18 |
Effective Chemicals against Novel Coronavirus (COVID-19) in China |
Wei Liu |
15 |
[GO] |
2022―Oct―18 |
Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China |
Zhang Qi |
16 |
[GO] |
2022―Oct―18 |
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery |
Ariane Sternberg |
17 |
[GO] |
2022―Aug―03 |
Coronavirus Disease COVID-19: A New Threat to Public Health |
|
18 |
[GO] |
2022―Jul―27 |
Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview. |
Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin, Rachid Daoud, et al. (+2) Achraf El Allali, Driss Cherqaoui |
19 |
[GO] |
2022―Jul―17 |
The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area |
Meng, ZJ |
20 |
[GO] |
2022―Jul―07 |
Therapeutics for the management of cytokine release syndrome in COVID-19 |
Shampa Ghosh, Shantanu Durgvanshi, Sung Soo Han, Rakesh Bhaskar, Jitendra Kumar Sinha |
21 |
[GO] |
2022―Jul―07 |
Novel Therapeutic Strategies for the Management of Neuropathology and Neuroprotection in COVID-19 |
Cindy Bandala |
22 |
[GO] |
2022―May―17 |
COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology |
Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Noemí Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, et al. (+3) Luz Adriana Pichardo-Macías, Cindy Bandala, Saúl Gómez-Manzo |
23 |
[GO] |
2022―May―07 |
Mental disorders and poor COVID-19 prognosis: reevaluating the relationship through Ca2+/cAMP signalling |
Leandro Bueno Bergantin |
24 |
[GO] |
2022―Apr―27 |
A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds |
Juan A. Castillo-Garit, Yudith Cañizares-Carmenate, Hai Pham-The, Virginia Pérez-Doñate, Francisco Torrens, Facundo Pérez-Giménez |
25 |
[GO] |
2022―Apr―06 |
Potential Neuroprotective Effect of Cannabinoids in Covid-19 Patients. |
José Luis Cortes-Altamirano, Ariadna Yáñes-Pizaña, Samuel Reyes-Long, González-Maciel Angélica, Cindy Bandala, Herlinda Bonilla-Jaime, Alfonso Alfaro-Rodríguez |
26 |
[GO] |
2022―Apr―03 |
Vitamin D and its possible relationship to neuroprotection in COVID-19: evidence in the literature |
Saray Quintero-Fabián, Cindy Bandala, Luz Adriana Pichardo-Macías, Itzel Jatziri Contreras-García, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, et al. (+3) José Arturo Martínez-Orozco, Iván Ignacio- Mejía, Noemí Cárdenas-Rodríguez |
27 |
[GO] |
2022―Mar―08 |
BIBLIOMETRIC ANALYSIS: NANOTECHNOLOGY AND COVID-19 |
Claure Nain Lunardi, Fernanda Lima Subrinho, Mirella Paula de Freitas Barros, Raiane Cavalcante Lima, Ana Clara Magalhaes de Queiroz Melo, Daniela de Melo Barbosa, et al. (+6) Luana Gouveia De Negreiros, Brenda Soares Rodrigues, Mateus Sousa Neiva, Joao Victor Ribeiro Linhares, Gabriel Farrapeira Dalla Costa, Anderson de Jesus Gomes |
28 |
[GO] |
2022―Mar―04 |
HDAC inhibition as neuroprotection in COVID-19 infection |
Yudibeth Sixto-López, José Correa-Basurto |
29 |
[GO] |
2021―Jul―28 |
Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment |
Harekrishna Roy, Asha Gummadi, Bhabani Shankar Nayak, Sisir Nandi, Anil Kumar Saxena |
30 |
[GO] |
2021―Jul―19 |
Protease Inhibitors as Promising Weapons against COVID-19: Focus on Repurposing of Drugs Used to Treat HIV and HCV infections |
Luciana Jesus da Costa, Matheus Mendonça Pereira, Lívia de Souza Ramos, Thaís Pereira de Mello, Laura Nunes Silva, Marta Helena Branquinha, André Luis Souza dos Santos |
31 |
[GO] |
2021―Jun―19 |
Chimeric virus-like particles of universal antigen epitopes of coronavirus and phage Qβ coat protein trigger the production of neutralizing antibodies |
Yukun Guo, Ruizhen Guo, Yingxian Ma, Wenru Chang, Shengli Ming, Guoyu Yang, Yujie Guo |
32 |
[GO] |
2021―Jun―15 |
COVID-19 and diabetes mellitus: potential metabolic associations |
Pedro Henrique Abreu da Silva, Andressa Santos Garcia, Fábio Aguiar Alves, André Luis Souza dos Santos, Cátia Lacerda Sodré |
33 |
[GO] |
2021―May―13 |
The effect of recombinant human interferon alpha nasal drops to prevent COVID-19 pneumonia for medical staff in an epidemic area |
Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, et al. (+2) Hai Li, Jie Luo |
34 |
[GO] |
2021―Mar―31 |
Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance |
Gabriela Seabra, Roberta Ferreira Ventura Mendes, Luiz Felipe Vieira dos Santos Amorim, Ingrid Vianez Peregrino, Marta Helena Branquinha, André Luis Souza dos Santos, Ana Paula Ferreira Nunes |
35 |
[GO] |
2021―Jan―19 |
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery |
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong |
36 |
[GO] |
2020―Dec―08 |
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors |
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong |
37 |
[GO] |
2020―Nov―13 |
Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses |
Arti Sharma, Kajal Kaliya, Sushil K. Maurya |
38 |
[GO] |
2020―Nov―03 |
Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents |
Anuraj Nayarisseri |
39 |
[GO] |
2020―Oct―01 |
Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic |
Mohamed Abouleish, Ali El-Keblawy, Kareem A. Mosa, Sameh S.M. Soliman |
40 |
[GO] |
2020―Oct―01 |
Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options |
Laura Nunes Silva, Thaís Pereira de Mello, Lívia de Souza Ramos, Marta Helena Branquinha, Maryam Roudbary, André Luis Souza dos Santos |
41 |
[GO] |
2020―Sep―23 |
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2 |
Satya P. Gupta |
42 |
[GO] |
2020―Jul―20 |
COVID-19: Small-Molecule Clinical Trials Landscape |
Leonardo L.G. Ferreira, Adriano D. Andricopulo |
43 |
[GO] |
2020―Jul―17 |
Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV) |
Gabriela Cristina Soares Rodrigues, Mayara dos Santos Maia, Renata Priscila Barros de Menezes, Andreza Barbosa Silva Cavalcanti, Natália Ferreira de Sousa, Érika Paiva de Moura, et al. (+3) Alex France Messias Monteiro, Luciana Scotti, Marcus Tullius Scotti |
44 |
[GO] |
2020―Jul―16 |
Therapeutic targets and computational approaches on drug development for COVID-19 |
Anusuya Shanmugam, Nisha Muralidharan, D. Velmurugan, M. Michael Gromiha |
45 |
[GO] |
2020―Jul―04 |
Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. |
Ravina Khandelwal, Anuraj Nayarisseri, Maddala Madhavi, Chandrabose Selvaraj, Umesh Panwar, Khushboo Sharma, et al. (+2) Tajamul Hussain, Sanjeev Kumar Singh |
46 |
[GO] |
2020―May―19 |
The Evolution of Computational Chemistry Along with Coronaviruses |
Weng Ieong Tou, Kuok Wa Tam, Hou Ng |
47 |
[GO] |
2020―May―17 |
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery |
Ariane Sternberg, Dwight L. McKee, Cord Naujokat |
48 |
[GO] |
2020―May―12 |
COVID-19 Pandemic - Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis? |
Yogesh Kumar, Akanksha Jain |
49 |
[GO] |
2020―May―12 |
COVID-19: An Update on Clinical Trials |
Yogesh Kumar, Anil Kumar Singh, Shiv Kumar |
50 |
[GO] |
2020―May―12 |
Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China |
Zhang Qi, Yu Yu |
51 |
[GO] |
2020―Apr―13 |
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time |
Amit Kumar Banerjee, Neelima Arora |
52 |
[GO] |
2020―Mar―05 |
Effective Chemicals against Novel Coronavirus (COVID-19) in China |
Wei Liu, Hai-liang Zhu, Yongtao Duan |
53 |
[GO] |
2020―Mar―05 |
Coronavirus Disease COVID-19: A New Threat to Public Health |
Sumit Kumar, Brijesh Rathi |
54 |
[GO] |
2020―Mar―05 |
China Coronavirus Outbreak: All the Latest Updates |
Luciana Scotti, Marcus T. Scotti |